Minerva Neurosciences Inc.
NERV | NASDAQ
$3.75
+$0.07 (+1.90%)
Sep 22, 2026, 11:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41.18M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41.18M |
Operating Income | -10.67B | -27.87M | -15.1M | -14.64M | -16.17M | -19.07M | -21.85M | -24.5M | -26.21M | -24.45M | -23.12M | -21.02M | -20.15M | -22.59M | -25.23M | -41.54M | -43.85M | -45.85M | -45.37M | -31.29M | -31.86M | 6.61M |
Interest Income | 1.28M | 1.42M | 948.6K | 641.32K | 848.65K | 1.07M | 1.27M | 1.39M | 1.43M | 1.43M | 1.44M | 1.64M | 1.47M | 1.17M | 816.83K | 259.89K | 79.8K | 7.42K | n/a | n/a | n/a | n/a |
Pretax Income | 16.24B | -415.07M | -293.42M | -14.03M | 11.23M | 6.25M | 1.44M | -3.31M | -33.65M | -31.6M | -30.01M | -27.71M | -26.79M | -29.31M | -32.11M | -48.49M | -50.8M | -52.67M | -51.71M | -35.92M | -34.83M | 5.29M |
Net Income | 16.24B | -415.07M | -293.42M | -14.03M | 11.23M | 6.25M | 1.44M | -3.31M | -33.65M | -31.6M | -30.01M | -27.71M | -26.79M | -29.31M | -32.11M | -46.69M | -48.99M | -50.87M | -49.91M | -35.92M | -34.83M | 5.29M |
Selling & General & Admin | 14.88B | 11.42B | 9.34M | 9.07M | 9.63M | 9.98M | 9.95M | 9.86M | 10.02M | 10.23M | 10.41M | 9.84M | 10.05M | 10.25M | 10.58M | 11.33M | 11.5M | 12.11M | 13.33M | 14.44M | 14.89M | 17.35M |
Research & Development | 12.45B | 5.26B | 5.76M | 5.57M | 6.53M | 9.09M | 11.9M | 14.64M | 16.19M | 14.22M | 12.71M | 11.17M | 10.1M | 12.34M | 14.65M | 30.21M | 32.35M | 33.74M | 32.04M | 16.84M | 16.97M | 17.22M |
Other Expenses | -16.65B | -16.65B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.67B | 27.87M | 15.1M | 14.64M | 16.17M | 19.07M | 21.85M | 24.5M | 26.21M | 24.45M | 23.12M | 21.02M | 20.15M | 22.59M | 25.23M | 41.54M | 43.85M | 45.85M | 45.37M | 31.29M | 31.86M | 34.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 2.31M | 4.56M | 6.75M | 8.84M | 8.56M | 8.28M | 8.02M | 7.81M | 7.61M | 7.41M | 7.21M | 7.02M | 6.81M | 6.33M | 4.59M | 2.91M | 1.3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.5M | 27.87M | 15.1M | 14.64M | 16.17M | 19.07M | 21.85M | 24.5M | 26.21M | 24.45M | 23.12M | 21.02M | 20.15M | 22.59M | 25.23M | 41.54M | 43.85M | 45.85M | 45.37M | 31.29M | 31.86M | 34.57M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.8M | -1.8M | -1.8M | -1.8M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 46.6M | 43.9M | 11.12M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 5.51M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M |
Shares Outstanding (Diluted) | 79.11M | 43.9M | 11.12M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M | 5.51M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M | 5.34M |
EPS (Basic) | -28.37 | -29.16 | -26.80 | -1.85 | 1.48 | 0.82 | 0.19 | -0.44 | -4.44 | -4.47 | -4.65 | -4.72 | -5.30 | -5.80 | -6.32 | -9.05 | -9.16 | -9.52 | -9.34 | -6.75 | -6.58 | 1.40 |
EPS (Diluted) | -28.87 | -29.16 | -26.80 | -1.85 | 1.48 | 0.82 | 0.19 | -0.44 | -4.44 | -4.47 | -4.65 | -4.72 | -5.30 | -5.80 | -6.32 | -9.05 | -9.16 | -9.52 | -9.34 | -6.75 | -6.58 | 1.24 |
EBITDA | -11.05B | -415.07M | -293.42M | -14.02M | 11.24M | 8.58M | 6.02M | 3.47M | -24.78M | -23.02M | -21.69M | -19.66M | -18.96M | -21.69M | -24.69M | -41.28M | -43.76M | -45.8M | -45.28M | -31.16M | -31.72M | 6.74M |
EBIT | -411.82M | -415.07M | -293.42M | -14.03M | 11.23M | 8.57M | 6M | 3.44M | -24.81M | -23.05M | -21.72M | -19.69M | -18.98M | -21.71M | -24.7M | -41.28M | -43.77M | -45.86M | -45.38M | -31.3M | -31.9M | 6.61M |
Depreciation & Amortization | 2.72K | 4.08K | 5.44K | 5.44K | 9.7K | 16.09K | 22.47K | 28.86K | 30.98K | 30.98K | 30.98K | 29.62K | 24K | 16.26K | 8.51K | 2.13K | 14.94K | 58.95K | 101.79K | 146.38K | 176.36K | 176.19K |
Add to Watchlist
Select watchlists to add or remove NERV